President Joe Biden announced on Monday that the US would begin shipping 20 million doses of Pfizer-BioNTech, Moderna, and Johnson & Johnson’s Covid-19 vaccine to unspecified needy countries by the end of June, in addition to the 60 million shots of AstraZeneca’s that have already been pledged for delivery subject to drug regulator approval.
While there are no details about how many of the 80 million doses will be distributed or to which countries, it is widely assumed that India will be one of the recipients. But, once again, no news on what it would get — AstraZeneca’s Covishield, which is already manufactured and sold in India, or Pfizer-BioNTech, Moderna, and Johnson & Johnson’s.
While AstraZeneca’s vaccine has not yet been approved for use in the United States — it has not yet applied for it — the company has agreed to supply 60 million doses if it is. Canada and Mexico, the two nearest neighbours, have already committed four million of them.
“Today, I’m announcing that, as vaccine doses from Pfizer, Moderna, and Johnson & Johnson become available, we’ll share them with the rest of the world as well,” Biden said.